Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 9661

BillFederalHouseIn Committee
To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.
About This Bill
Committee
Latest Action · July 14, 2026
Referred to the House Committee on Energy and Commerce.
Introduced
July 14, 2026
Cosponsors (2)
1D 1R
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.